Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VECOL S.A. is a leading Colombian company specializing in the research, development, manufacturing, and commercialization of biotechnological products—primarily vaccines—and pharmaceuticals for animal health. The company also produces nutritional supplements as well as agrochemicals such as herbicides and fertilizers. It has a strong presence in both the production animal sector (bovines/cattle, pigs/swine/porcines, sheep/goats/ovicaprines/equines/poultry) and the companion animal market. Its flagship products include foot-and-mouth disease vaccines for livestock—where it holds industry leadership—and rabies vaccines for pets ("Rabicán"). The company exports to several Latin American countries and partners with international firms like Catalysis to distribute nutraceuticals targeting chronic pet conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VECOL.